151 related articles for article (PubMed ID: 32885566)
1. The epidemiological characteristics of thromboembolism related to oral contraceptives in Japan: Results of a national survey.
Sugiura K; Kobayashi T; Ojima T
J Obstet Gynaecol Res; 2021 Jan; 47(1):198-207. PubMed ID: 32885566
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolism as the adverse event of combined oral contraceptives in Japan.
Sugiura K; Kobayashi T; Ojima T
Thromb Res; 2015 Dec; 136(6):1110-5. PubMed ID: 26475406
[TBL] [Abstract][Full Text] [Related]
3. National survey of confirmed thromboembolism related to female hormones in Japan.
Sugiura K; Kobayashi T; Ojima T
J Obstet Gynaecol Res; 2020 Jul; 46(7):1173-1182. PubMed ID: 32452142
[TBL] [Abstract][Full Text] [Related]
4. The incidence and prognosis of thromboembolism associated with oral contraceptives: Age-dependent difference in Japanese population.
Sugiura K; Ojima T; Urano T; Kobayashi T
J Obstet Gynaecol Res; 2018 Sep; 44(9):1766-1772. PubMed ID: 29998477
[TBL] [Abstract][Full Text] [Related]
5. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
6. Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women.
Kobayashi T; Sugiura K; Ojima T
J Obstet Gynaecol Res; 2017 May; 43(5):789-797. PubMed ID: 28422361
[TBL] [Abstract][Full Text] [Related]
7. Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women.
Sugiura K; Kobayashi T; Ojima T
Thromb Res; 2016 Jan; 137():11-16. PubMed ID: 26672897
[TBL] [Abstract][Full Text] [Related]
8. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
9. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database.
Li J; Panucci G; Moeny D; Liu W; Maro JC; Toh S; Huang TY
JAMA Intern Med; 2018 Nov; 178(11):1482-1488. PubMed ID: 30285041
[TBL] [Abstract][Full Text] [Related]
10. Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.
Larivée N; Suissa S; Eberg M; Joseph L; Eisenberg MJ; Abenhaim HA; Filion KB
BJOG; 2017 Oct; 124(11):1672-1679. PubMed ID: 27704723
[TBL] [Abstract][Full Text] [Related]
11. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
Schink T; Princk C; Braitmaier M; Haug U
BJOG; 2022 Dec; 129(13):2107-2116. PubMed ID: 35876787
[TBL] [Abstract][Full Text] [Related]
12. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
13. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
Samuelsson E; Hägg S
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
[TBL] [Abstract][Full Text] [Related]
14. Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives--an approach to specifying rates.
Samuelsson E; Hedenmalm K; Persson I
Eur J Epidemiol; 2005; 20(6):509-16. PubMed ID: 16121760
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.
Farmer RD; Lawrenson RA; Todd JC; Williams TJ; MacRae KD; Tyrer F; Leydon GM
Br J Clin Pharmacol; 2000 Jun; 49(6):580-90. PubMed ID: 10848722
[TBL] [Abstract][Full Text] [Related]
16. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
17. Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism.
Reed S; Koro C; DiBello J; Becker K; Bauerfeind A; Franke C; Heinemann K
Eur J Contracept Reprod Health Care; 2021 Dec; 26(6):439-446. PubMed ID: 34644228
[TBL] [Abstract][Full Text] [Related]
18. Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reporting.
Hedenmalm K; Samuelsson E
Drug Saf; 2005; 28(10):907-16. PubMed ID: 16180940
[TBL] [Abstract][Full Text] [Related]
19. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome.
Hedenmalm K; Samuelsson E; Spigset O
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):576-85. PubMed ID: 15144341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]